Jane Street
CTXR icon

Jane Street’s Citius Pharmaceuticals CTXR Stock Holding History

Jane Street’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.3K Buy
22,523
+4,565
+25% +$3.69K ﹤0.01% 11189
2025
Q4 		$14K Sell
17,958
-927
-5% -$1.16K ﹤0.01% 10788
2025
Q3 		$23.4K Buy
+18,885
New +$26.3K ﹤0.01% 10507
2024
Q4 		– Sell
-3,738
Closed -$46.8K – 9558
2024
Q3 		$46.8K Sell
3,738
-11,603
-76% -$195K ﹤0.01% 9190
2024
Q2 		$224K Buy
15,341
+12,203
+389% +$219K ﹤0.01% 8224
2024
Q1 		$70.4K Sell
3,138
-810
-21% -$14.8K ﹤0.01% 8662
2023
Q4 		$74.7K Buy
+3,948
New +$74.9K ﹤0.01% 8681
2023
Q3 		– Sell
-2,871
Closed -$86.1K – 8735
2023
Q2 		$86.1K Sell
2,871
-6,970
-71% -$229K ﹤0.01% 8065
2023
Q1 		$288K Buy
9,841
+9,000
+1,070% +$259K ﹤0.01% 7268
2022
Q4 		$16.6K Sell
841
-384
-31% -$10.5K ﹤0.01% 8648
2022
Q3 		$37K Buy
+1,225
New +$33.7K ﹤0.01% 9031
2022
Q1 		– Sell
-1,639
Closed -$63K – 10381
2021
Q4 		$63K Buy
+1,639
New +$74.3K ﹤0.01% 9445
2021
Q2 		– Sell
-2,214
Closed -$99K – 9849
2021
Q1 		$99K Buy
+2,214
New +$88.2K ﹤0.01% 8653
2020
Q1 		– Sell
-435
Closed -$11K – 5374
2019
Q4 		$11K Buy
+435
New +$6.37K ﹤0.01% 4964

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street's CTXR Position: Q1 2026 in Review

Jane Street increased its Citius Pharmaceuticals (CTXR) stake by 25% in Q1 2026, buying an estimated $3.69K and bringing the position to 22,523 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #11189.

Jane Street first reported a position in CTXR in Q4 2019 and has held it in 14 quarters since. The position peaked at $288K in Q1 2023. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • Jane Street held 22,523 shares of Citius Pharmaceuticals worth $20.3K as of Q1 2026.
  • Jane Street bought 4,565 Citius Pharmaceuticals shares in Q1 2026, an estimated $3.69K.
  • Citius Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11189 holding.
  • Jane Street first reported a position in Citius Pharmaceuticals in Q4 2019 and has held it in 14 quarters since.
  • Jane Street's Citius Pharmaceuticals position peaked at $288K in Q1 2023.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.